Business Development Containment Pharmacy 
Pharmaceutical Technology
SEPTEMBER 7, 2022
Increasing diagnosis of chronic diseases is expected to lead to fast growth in retail pharmacies. The rising incidence of long-standing diseases such as hypertension, diabetes, cardiovascular diseases, and cancer requires prolonged medication and, thus, drives the growth and need for retail pharmacies in the market. Speciality care.
Pharmaceutical Technology
SEPTEMBER 8, 2022
Speciality pharmacies play a crucial role in medication dosing, disease and side effects management, and patient care. Speciality pharmacies provide comprehensive medications for individuals with serious medical conditions requiring complex treatments, including cancer, cystic fibrosis, haemophilia, hepatitis, HIV, and others.
This site is protected by reCAPTCHA and the Google Privacy Policy and Terms of Service apply.
Pharmaceutical Technology
SEPTEMBER 7, 2022
The download contains detailed information on the providers and their services and solutions, alongside contact details to aid your purchasing decision. Patient adherence. Pharmaceutical companies are increasingly integrating data-driven and software-centric medical adherence products to improve patient compliance.
Pharmaceutical Technology
SEPTEMBER 5, 2022
Wholesale pharmaceutical companies also offer services such as end formulation contracts, which help pharmaceutical marketing companies and pharmacies locate manufacturing units across regions and coordinate negotiations when required. Discover the top pharmaceutical wholesalers. Worldwide sourcing and drop-ship of orphan medicines, and.
Pharmaceutical Technology
SEPTEMBER 8, 2022
Increasing drug failure rates and essential drug shortages have driven the growth of the compounding pharmacies market, which has a high growth potential, especially in emerging economies. Test method development. Discover the top pharmaceutical compounding companies in contract marketing.
Pharmaceutical Technology
SEPTEMBER 20, 2022
The information contained within the download document is intended for pharmaceutical manufacturers, wholesalers, retailers and distributors, pharmaceutical executives, medical representatives, business development managers, retail salesmen, sales managers, pharmacy executives, and any other individual involved in pharmaceutical marketing.
pharmaphorum
JANUARY 28, 2021
This milestone is also significant because insulin is covered under the Part D pharmacy benefit, and now, insulin biosimilars will be, too. This is the first market where a biosimilar product could be dispensed in the retail pharmacy setting, since the other biosimilars currently on the US market are covered via Part B.
Expert insights. Personalized for you.
113 
Let's personalize your content